The New OPEC
The two companies whose stories we tell this week will continue to dominate the global semiconductor supply chain for years to come – and are the two best ideas to capitalize on today’s parallel-processing revolution.
Porter & Co.
The Big Bang That No One Noticed
This is the first installment of our month-long Parallel-Processing Revolution series… an in-depth view of a revolutionary tech investment story no one else is talking about. Since this year marks Porter & Co.’s second anniversary, we are making this vital four-part series free to all our readers.
The Drugmaker’s Hidden Jewel
In this month’s issue, we focus on a drugmaker that has one hidden asset that ties all its other assets together and acts as a value multiplier for them: and it has a spectacular track record of success that traces back to the company’s origins.
The Disrupters
Skirting the law for more than five years gave this company a huge advantage, enabling it to gobble up market share, so that now as the dominant player, it can use its size to power long-term growth.
An Open Forum With Activist Investor’s Tom Carroll
We are excited to share with you this latest Porter & Co. Open Forum – a new feature to allow readers to ask questions of analysts from all our research advisories. Below we bring you a discussion between Activist Investor editor Tom Carroll and publisher Kim Iskyan. In this “ask me anything” format, readers brought
The Low Price of High-Yield Bonds
The distressed-bond universe exhibits a rare market condition that in the past has produced an average annual return of 73%. On the face of it, as we discuss in this issue, this condition could prove to be an excellent time to be buying distressed debt.
We Don’t Need Your Debt, America
The recent surge in foreign banks buying gold has occurred alongside a sharp decline in their purchases of U.S. Treasury debt. The result could ultimately lead to a “debt doom loop”.
If Vans Gets Its Groove Back, VFC Shares Will Rise
With the share price down and with a handful of catalysts likely to drive the price higher, we provide an update on V.F. Corporation – and look at three other stocks in the portfolio as well: OneSpan, Orthofix Medical, and Mercury Systems.
The 50% Compounder You’ve Never Heard Of
While non-standard insurance policies guard against high-risk events – like Kiss’ Gene Simmons hurting his tongue or Bruce Springsteen losing his voice – this doesn’t necessarily make for a riskier business model as we show with this highly profitable company that is eating up market share.